This episode takes a global health perspective to look at different barriers to the elimination of hepatitis C, in Europe and globally. Diagnosing HCV is one of the key challenges to elimination – how does political will and infrastructure factor into this? What can be done at the EU level to address these barriers? What major challenges do low and middle-income countries face with respect to hepatitis C diagnosis?




Loreta Kondili

Prof. Loreta Kondili is a specialist in Gastroenterology and Digestive Endoscopy since 2005 and earned her Ph.D. degree in 2015. She is trained in Sapienza University and Policlinico Umberto 1- Rome and in the Liver Unit of Queen Elisabeth Hospital/ University of Birmingham (UK). She is a Clinical Researcher at the Center for Global Health, Istituto Superiore di Sanità, Rome. Prof. Kondili has worked in viral hepatitis and liver diseases for the last 25 years, and her main research areas focus on epidemiological, clinical, and therapy of chronic viral liver disease. She has been involved in the scientific coordination of several Italian Networks in the field of chronic liver disease of different etiologies with specific regard to chronic viral hepatitis, liver cirrhosis, and its complications. She is currently the principal investigator of the Italian Platform for the study of Viral Hepatitis Therapies (PITER). She has strong competencies in the Health Technology Assessment and management and analysis of real-life big databases. She has collaborated with the Center for Economic and International Studies (CEIS) of the Tor Vergata University of Rome and the Center for Disease Analysis Colorado (USA), for the definition of the HCV elimination strategies in Italy as a goal of the World Health Organization. She is currently serving as expert for the Italian Ministry of Health on the implementation of the National Hepatitis plan. She has been an expert of the Italian Drug Agency (AIFA) and is currently serving as expert at European Medicines Agency (EMA) She is a Professor of Medicine at the University of Tirana. She passed the National Scientific Qualification as Associated Professor (Bando D.D. 1532/2016 Settore concorsuale 06/D4 Fascia: II). She holds a 2nd level master’s in Evaluation and Management of Health Technologies from the Catholic University of Rome. She is a member of the Italian Association for the Study of the Liver and of the European Association for the Study of the Liver (EASL) serving also as a member of the Policy and Public Health Committee of EASL. Prof Kondili has co-authored over 100 publications on hepatitis and is a frequent speaker in national and international scientific meetings.

Sonjelle Shilton

Sonjelle Shilton joined the Foundation for Innovative New Diagnostics (FIND) in January 2017 and is currently Deputy Director, Operational Implementation Research, Foundation for Innovative New Diagnostics (FIND). Sonjelle started her career in public health as Director of Operations of HardtHaven, a community-based health outreach organization in rural Ghana. She has over fifteen years of experience in leading programmes and implementation science studies. Her time in Ghana cemented her dedication to public health approaches that are collaboratively designed and implemented with rigorous and meaningful data capture. She attained a Master of Global Public Health and the Global WACh Graduate Certificate for integrated health of Women, Adolescents and Children from the University of Washington, USA.